|
||
The Journal of General Physiology, Vol 104, 425-447, Copyright © 1994 by The Rockefeller University Press
ARTICLES |
AR Lindsay, A Tinker and AJ Williams
Department of Cardiac Medicine, National Heart and Lung Institute, University of London, United Kingdom.
Under appropriate conditions, the interaction of the plant alkaloid ryanodine with a single cardiac sarcoplasmic reticulum Ca(2+)-release channel results in a profound modification of both channel gating and conduction. On modification, the channel undergoes a dramatic increase in open probability and a change in single-channel conductance. In this paper we aim to provide a mechanistic framework for the interpretation of the altered conductance seen after ryanodine binding to the channel protein. To do this we have characterized single-channel conductance with representative members of three classes of permeant cation; group 1a monovalent cations, alkaline earth divalent cations, and organic monovalent cations. We have quantified the change in single-channel conductance induced by ryanodine and have expressed this as a fraction of conductance in the absence of ryanodine. Fractional conductance seen in symmetrical 210 mM solutions is not fixed but varies with the nature of the permeant cation. The group 1a monovalent cations (K+, Na+, Cs+, Li+) have values of fractional conductance in a narrow range (0.60- 0.66). With divalent cations fractional conductance is considerably lower (Ba2+, 0.22 and Sr2+, 0.28), whereas values of fractional conductance vary considerably with the organic monovalent cations (ammonia 0.66, ethylamine 0.76, propanolamine 0.65, diethanolamine 0.92, diethylamine 1.2). To establish the mechanisms governing these differences, we have monitored the affinity of the conduction pathway for, and the relative permeability of, representative cations in the ryanodine-modified channel. These parameters have been compared with those obtained in previous studies from this laboratory using the channel in the absence of ryanodine and have been modeled by modifying our existing single-ion, four-barrier three-well rate theory model of conduction in the unmodified channel. Our findings indicate that the high affinity, essentially irreversible, interaction of ryanodine with the cardiac sarcoplasmic reticulum Ca(2+)-release channel produces a conformational alteration of the protein which results in modified ion handling. We suggest that, on modification, the affinity of the channel for the group 1a monovalent cations is increased while the relative permeability of this class of cations remains essentially unaltered. The affinity of the conduction pathway for the alkaline earth divalent cations is also increased, however the relative permeability of this class of cations is reduced compared to the unmodified channel. The influence of modification on the handling by the channel of the organic monovalent cations is determined by both the size and the nature of the cation.(ABSTRACT TRUNCATED AT 400 WORDS)
This article has been cited by other articles:
![]() |
B. Tanna, W. Welch, L. Ruest, J. L. Sutko, and A. J. Williams The Interaction of an Impermeant Cation with the Sheep Cardiac RyR Channel Alters Ryanoid Association Mol. Pharmacol., June 1, 2006; 69(6): 1990 - 1997. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tanna, W. Welch, L. Ruest, J. L. Sutko, and A. J. Williams Voltage-Sensitive Equilibrium between Two States within a Ryanoid-Modified Conductance State of the Ryanodine Receptor Channel Biophys. J., April 1, 2005; 88(4): 2585 - 2596. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Welch, S. Rheault, D. J. West, and A. J. Williams A Model of the Putative Pore Region of the Cardiac Ryanodine Receptor Channel Biophys. J., October 1, 2004; 87(4): 2335 - 2351. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tanna, W. Welch, L. Ruest, J. L. Sutko, and A. J. Williams An Anionic Ryanoid, 10-O-succinoylryanodol, Provides Insights into the Mechanisms Governing the Interaction of Ryanoids and the Subsequent Altered Function of Ryanodine-receptor Channels J. Gen. Physiol., May 27, 2003; 121(6): 551 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Tsushima, J. E. Kelly, and J. A. Wasserstrom Subconductance Activity Induced by Quinidine and Quinidinium in Purified Cardiac Sarcoplasmic Reticulum Calcium Release Channels J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 729 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Du, X. Guo, V. K. Khanna, and D. H. MacLennan Ryanodine sensitizes the cardiac Ca2+ release channel (ryanodine receptor isoform 2) to Ca2+ activation and dissociates as the channel is closed by Ca2+ depletion PNAS, October 31, 2001; (2001) 241516898. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Masumiya, P. Li, L. Zhang, and S. R. W. Chen Ryanodine Sensitizes the Ca2+ Release Channel (Ryanodine Receptor) to Ca2+ Activation J. Biol. Chem., October 19, 2001; 276(43): 39727 - 39735. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Gurrola, C. Arevalo, R. Sreekumar, A. J. Lokuta, J. W. Walker, and H. H. Valdivia Activation of Ryanodine Receptors by Imperatoxin A and a Peptide Segment of the II-III Loop of the Dihydropyridine Receptor J. Biol. Chem., March 19, 1999; 274(12): 7879 - 7886. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zucchi and S. Ronca-Testoni The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. El-Hayek, A. J. Lokuta, C. Arévalo, and H. H. Valdivia Peptide Probe of Ryanodine Receptor Function J. Biol. Chem., December 1, 1995; 270(48): 28696 - 28704. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Du, X. Guo, V. K. Khanna, and D. H. MacLennan Ryanodine sensitizes the cardiac Ca2+ release channel (ryanodine receptor isoform 2) to Ca2+ activation and dissociates as the channel is closed by Ca2+ depletion PNAS, November 20, 2001; 98(24): 13625 - 13630. [Abstract] [Full Text] [PDF] |
||||
|
|